A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Clinical Site, New York

Clinical Site, Monroeville

Clinical Site, Chambersburg

Clinical Site, Hagerstown

Clinical Site, Norfolk

Clinical Site, Sarasota

Clinical Site, Marietta

Clinical Site, Augusta

Clinical Site, Clearwater

Clinical Site, Pinellas Park

Clinical Site, Winter Haven

Clinical Site, Germantown

Clinical Site, Indianapolis

Clinical Site, Madison

Clinical Site, Edina

Clinical Site, Rapid City

Clinical Site, Lemont

Clinical Site, Downers Grove

Clinical Site, Springfield

Clinical Site, St Louis

Clinical Site, Dallas

Clinical Site, Arlington

Clinical Site, Grapevine

Clinical Site, Willow Park

Clinical Site, Houston

Clinical Site, The Woodlands

Clinical Site, San Antonio

Clinical Site, San Antonio

Clinical Site, McAllen

Clinical Site, Amarillo

Clinical Site, Abilene

Clinical Site, Golden

Clinical Site, Salt Lake City

Clinical Site, Tucson

Clinical Site, Albuquerque

Clinical Site, Beverly Hills

Clinical Site, Long Beach

Clinical Site, Arcadia

Clinical Site, Glendale

Clinical Site, Poway

Clinical Site, Palm Desert

Clinical Site, Laguna Hills

Clinical Site, Tustin

Clinical Site, Oxnard

Clinical Site, Santa Maria

Clinical Site, Mountain View

Clinical Site, Campbell

Clinical Site, Sacramento

Clinical Site, Hamden

Clinical Site, Bloomfield